These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 1384716)

  • 21. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
    Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
    Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Ann N Y Acad Sci; 1996 Jan; 777():121-31. PubMed ID: 8624074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alzheimer's disease: cellular and molecular aspects].
    Octave JN; Pierrot N
    Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
    Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
    Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease.
    Praprotnik D; Smith MA; Richey PL; Vinters HV; Perry G
    Acta Neuropathol; 1996; 91(3):226-35. PubMed ID: 8834534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein.
    Nukina N; Kosik KS; Selkoe DJ
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3415-9. PubMed ID: 3106969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subpopulations of dystrophic neurites [correction of neuritis] in Alzheimer's brain with distinct immunocytochemical and argentophilic characteristics.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1994 Feb; 637(1-2):37-44. PubMed ID: 8180819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of tau proteins in Alzheimer's disease. Evidence for increased expression of an isoform and preferential distribution of a phosphorylated isoform in neurites.
    Liu WK; Dickson DW; Yen SH
    Am J Pathol; 1993 Feb; 142(2):387-94. PubMed ID: 7679548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
    Goedert M
    Arzneimittelforschung; 1995 Mar; 45(3A):403-9. PubMed ID: 7763334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical examination of phosphorylated tau in granulovacuolar degeneration granules.
    Ikegami K; Kimura T; Katsuragi S; Ono T; Yamamoto H; Miyamoto E; Miyakawa T
    Psychiatry Clin Neurosci; 1996 Jun; 50(3):137-40. PubMed ID: 9201760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Truncated tau protein as a new marker for Alzheimer's disease.
    Novák M
    Acta Virol; 1994 Jun; 38(3):173-89. PubMed ID: 7817900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
    Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
    Masliah E; Sisk A; Mallory M; Games D
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):357-68. PubMed ID: 11305871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites.
    Su JH; Cummings BJ; Cotman CW
    Neuroreport; 1994 Nov; 5(17):2358-62. PubMed ID: 7533559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.
    Kosik KS; Joachim CL; Selkoe DJ
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4044-8. PubMed ID: 2424016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo.
    Vergara C; Houben S; Suain V; Yilmaz Z; De Decker R; Vanden Dries V; Boom A; Mansour S; Leroy K; Ando K; Brion JP
    Acta Neuropathol; 2019 Mar; 137(3):397-412. PubMed ID: 30599077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dystrophic neurites infiltrate extracellular neurofibrillary tangles in Alzheimer disease.
    Vande Weghe J; Cras P; Kawai M; Siedlak SL; Tabaton M; Greenberg B; Perry G
    Brain Res; 1991 Sep; 560(1-2):303-5. PubMed ID: 1760735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoskeletal abnormalities in Alzheimer's disease.
    Lovestone S; Anderton B
    Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):883-8. PubMed ID: 1467582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.